23:49:11 EST Tue 17 Nov 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:FEMY - FEMASYS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FEMY - Q0.11.04·1.790.21.12-0.16-12.5110.61243341.29  1.305  1.0720.80  1.25519:59:01Nov 1315 min RT 2¢

Recent Trades - Last 10 of 334
Time ETExPriceChangeVolume
19:59:01Q1.18-0.1010
19:30:01Q1.12-0.161
16:15:00Q1.12-0.161
16:15:00Q1.1201-0.15991
16:13:59Q1.14-0.142
16:10:05Q1.12-0.161
16:10:04Q1.12-0.161
16:10:04Q1.12-0.161
16:04:06Q1.12-0.161
16:04:06Q1.12-0.161

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-11-13 16:05U:FEMYNews ReleaseFemasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
2026-10-30 09:00U:FEMYNews ReleaseFemasys Appoints John Moorhead to Board of Directors
2026-10-20 09:00U:FEMYNews ReleaseFemasys Partners with SandsRx Pharmacy to Support FemaSeed(TM) Fertility Portfolio Launch to OB/GYNs
2026-10-14 09:00U:FEMYNews ReleaseFemasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
2026-10-08 09:00U:FEMYNews ReleaseFemasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
2026-09-15 09:00U:FEMYNews ReleaseFemasys Advances OB/GYN Expansion with Adoption of FemaSeed(TM) Fertility Portfolio by Minnesota Women's Care
2026-09-09 09:00U:FEMYNews ReleaseFemasys Partners with CapexMD to Expand Patient Access to FemaSeed(TM) Fertility Portfolio
2026-08-26 09:00U:FEMYNews ReleaseFemasys Partners with UNC Health to Introduce Its FemaSeed(TM) Fertility Portfolio Across Statewide OB/GYN Care Locations
2026-08-19 09:00U:FEMYNews ReleaseFemasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc(TM)
2026-08-14 16:05U:FEMYNews ReleaseFemasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
2026-08-12 09:00U:FEMYNews ReleaseFemasys Strengthens and Extends Global Patent Protection for FemBloc(TM) with First Issued Blended Polymer Patents
2026-08-07 09:25U:FEMYNews ReleaseFemasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
2026-06-24 09:00U:FEMYNews ReleaseFemasys Regains Compliance with Nasdaq Listing Requirements
2026-05-13 09:00U:FEMYNews ReleaseFemasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG(TM) Catheter
2026-05-08 16:05U:FEMYNews ReleaseFemasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
2026-05-05 09:00U:FEMYNews ReleaseFemasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed(TM) Complete
2026-04-22 09:00U:FEMYNews ReleaseFemasys Launches FemaSeed(TM) Complete for OB/GYNs at ACOG 2026
2026-04-16 09:00U:FEMYNews ReleaseFemasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
2026-04-01 09:00U:FEMYNews ReleaseFemasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
2026-03-31 16:05U:FEMYNews ReleaseFemasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update